1. Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma
    Guan Wang et al, 2023, Scientific Reports CrossRef
  2. FAM72, Glioblastoma Multiforme (GBM) and Beyond
    Nguyen Thi Thanh Ho et al, 2021, Cancers CrossRef
  3. DNA methylation alterations at RE1-silencing transcription factor binding sites and their flanking regions in cancer
    Ana Florencia Vega-Benedetti et al, 2023, Clinical Epigenetics CrossRef
  4. Electron microscopy reveals toroidal shape of master neuronal cell differentiator REST – RE1-silencing transcription factor
    Pavel Veverka et al, 2023, Computational and Structural Biotechnology Journal CrossRef
  5. Overexpression of Fn14 in gliomas: tumor progression and poor prognosis
    Dan Tan et al, 2018, Future Oncology CrossRef
  6. miR-490 suppresses telomere maintenance program and associated hallmarks in glioblastoma
    Omkar Suhas Vinchure et al, 2021, Cellular and Molecular Life Sciences CrossRef
  7. Repressor element 1 silencing transcription factor /neuron-restrictive silencing factor (REST/NRSF) in social stress and depression
    Tomoko Soga et al, 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
  8. Roles of the Neuron-Restrictive Silencer Factor in the Pathophysiological Process of the Central Nervous System
    Xin-Jin Su et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  9. Expression of Repressor Element 1 Silencing Transcription Factor (REST) in Serotonin Neurons in the Adult Male Nile Tilapia (Oreochromis niloticus)
    Tomoko Soga et al, 2021, Frontiers in Neuroanatomy CrossRef
  10. The NRSF/REST transcription factor in hallmarks of cancer: From molecular mechanisms to clinical relevance
    Adán Arizmendi-Izazaga et al, 2023, Biochimie CrossRef
  11. News about the Role of the Transcription Factor REST in Neurons: From Physiology to Pathology
    Jose M. Garcia-Manteiga et al, 2019, International Journal of Molecular Sciences CrossRef
  12. Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
    Silvia Belluti et al, 2020, Cells CrossRef
  13. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
    Wan Zhang et al, 2024, Frontiers in Immunology CrossRef